Works matching DE "ELTROMBOPAG"

Results: 145

Portal vein thrombosis as a complication of Eltrombopag used in the treatment of immune thrombocytopenia in a patient of chronic liver disease.

Published in:

Indian Journal of Pharmacology, 2025, v. 57, n. 3, p. 193, doi. 10.4103/ijp.ijp_777_22

By:

Kamath, Sangita D.;
Kumar, Manish;
Saha, Sudip;
Sunder, Ashok

Publication type:

Article

Eltrombopag in severe immune thrombocytopenia secondary to connective tissue disease: a report of 17 patients and literature review.

Published in:

Clinical Rheumatology, 2023, v. 42, n. 5, p. 1451, doi. 10.1007/s10067-022-06464-w

By:

Li, Wenjing;
Wang, Dandan;
Ma, Ling;
Zhu, Yun;
Wang, Fan;
Hua, Bingzhu;
Wang, Hong;
Feng, Xuebing

Publication type:

Article

Eltrombopag for Adults and Children with Immune-Refractory Thrombocytopenic Purpura: A Systematic Review.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 12, p. 3872, doi. 10.3390/jcm12123872

By:

de Barros Torelli, Danielle Francisco Honorato;
Oliveira, Crystian Bitencourt Soares;
Nai, Gisele Alborghetti;
Trindade, Evelinda Marramon;
Prestes-Carneiro, Luiz Euribel

Publication type:

Article

Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-024-00803-0

By:

Inal, Ahmet;
Sezer, Zafer;
Pinarbasli, Onur;
Bulut, Burcu;
Reinsch, Martin;
Martin, Wolfgang;
Mazicioglu, Mumtaz M.;
Koru, Selma Alime

Publication type:

Article

Bioequivalence and Food Effect Assessment of Eltrombopag Olamine Tablets in Healthy Chinese Subjects: An Open, Randomized, Single‐Dose, and Two‐Period Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 11, p. 1260, doi. 10.1002/cpdd.1453

By:

Wang, Jingyan;
Zhao, Zhicheng;
Tao, Ye;
Lan, Yi

Publication type:

Article

Efficacy of Eltrombopag in Children with Post-Stem Cell Transplant Prolonged Isolated Thrombocytopenia.

Published in:

Hematology Reports, 2022, v. 14, n. 3, p. 240, doi. 10.3390/hematolrep14030033

By:

Megumi Matsumoto;
Kazuki Terada;
Taichiro Tsuchimochi;
Satoko Takahashi;
Yasushi Noguchi;
Shunji Igarashi

Publication type:

Article

Efficacy of eltrombopag on refractory primary immune thrombocytopenia and its effect on cellular immune function.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 9, p. 736, doi. 10.5246/jcps.2023.09.060

By:

Hanchun Yang;
Fei Cheng;
Juanjuan Huang

Publication type:

Article

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial.

Published in:

Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2224044

By:

Wan, Ziqi;
Chen, Miao;
Han, Bing

Publication type:

Article

Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia.

Published in:

Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2022.2135694

By:

Feifei Yang;
Hui Zong;
Feng Li;
Shulin Luo;
Xiuqun Zhang;
Yanli Xu;
Xuezhong Zhang

Publication type:

Article

Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia.

Published in:

Platelets, 2023, v. 34, n. 1, p. 1, doi. 10.1080/09537104.2022.2135694

By:

Yang, Feifei;
Zong, Hui;
Li, Feng;
Luo, Shulin;
Zhang, Xiuqun;
Xu, Yanli;
Zhang, Xuezhong

Publication type:

Article

Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.

Published in:

2022

By:

Arif, Abdul Rehman;
Zhao, Miaomiao;
Chen, Wenlan;
Xue, Mei;
Luo, Shanshan;
Wang, Yadan

Publication type:

Case Study

Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant.

Published in:

2022

By:

Tian, Hong;
Kong, Danqing;
Li, Yun;
Gu, Chengyuan;
Yu, Ziqiang;
Wang, Zhaoyue;
Wu, Depei;
Yin, Jie

Publication type:

Case Study

Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study.

Published in:

Platelets, 2022, v. 33, n. 1, p. 82, doi. 10.1080/09537104.2020.1847267

By:

Liu, Xiaofan;
Hou, Ming;
Li, Junmin;
Jin, Jie;
Huang, Meijuan;
Yu, Ziqiang;
Xu, Xiaojun;
Zhang, Xiaohui;
Yang, Renchi

Publication type:

Article

Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag.

Published in:

Platelets, 2020, v. 31, n. 8, p. 993, doi. 10.1080/09537104.2019.1702156

By:

Hernández-Sánchez, Jesús María;
Bastida, José María;
Alonso-López, Diego;
Benito, Rocío;
González-Porras, José Ramón;
De Las Rivas, Javier;
Hernández Rivas, Jesús María;
Rodríguez-Vicente, Ana Eugenia

Publication type:

Article

Successful use of eltrombopag for surgical preparation in a patient with ANKRD26 -related thrombocytopenia.

Published in:

2016

By:

Fiore, Mathieu;
Saut, Noémie;
Alessi, Marie-Christine;
Viallard, Jean-François

Publication type:

Case Study

Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.

Published in:

Platelets, 2015, v. 26, n. 1, p. 93, doi. 10.3109/09537104.2013.870333

By:

Tarantino, Michael D.;
Fogarty, Patrick F.;
Shah, Palvi;
Brainsky, Andrés

Publication type:

Article

Safety Profile of Eltrombopag in Different Age Groups: An Analysis of Real‐World Pharmacovigilance and Randomized Clinical Trials.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 201, doi. 10.1002/cpt.2918

By:

Qu, Han;
Wu, Jiaqi;
Ma, Cui;
Qiaolongbatu, Xijier;
Song, Xianmin;
Feng, Tingting;
Wu, Zhenghua;
Lou, Yuefen;
Fan, Guorong

Publication type:

Article

Health‐related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study.

Published in:

Angewandte Chemie, 2019, v. 131, n. 15, p. 102, doi. 10.1111/bjh.15732

By:

Grainger, John D.;
Blanchette, Victor S.;
Grotzinger, Kelly M.;
Roy, Anuja;
Bussel, James B.

Publication type:

Article

Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world.

Published in:

Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2619, doi. 10.1007/s10238-023-00989-3

By:

Li, Ruixin;
Wang, Ningling;
Chai, Xingxing;
Yang, Linhai;
Liu, Kangkang;
He, Hailong;
Lin, Shengyun;
Yang, Yan;
Jia, Jinsong;
Zhang, Donghua;
Gong, Yuemin;
Shi, Jinning;
He, Guangsheng;
Li, Jianyong

Publication type:

Article

Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211005555

By:

Ahmed, Hafiz Abdul Waqas;
Masoud, Ahmed Taher;
Han, Jia;
Adel Sofy, Ahmed;
Saeed Ahmed, Ahmed;
Abdesattart, Ahmed Taha;
Drokow, Emmanuel Kwateng;
Sun, Kai

Publication type:

Article

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem cell transplantation.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 2, p. 413, doi. 10.55730/1300-0144.5328

By:

KARATAŞ, Ayşe;
GÖKER, Hakan;
DEMİROĞLU, Haluk;
MALKAN, Ümit Yavuz;
VELET, Mustafa;
ÇINAR, Olgu Erkin;
ERDOĞDU, Batuhan;
KARADENİZ, Mine;
SAYINALP, Nilgün;
AKSU, Salih;
HAZNEDAROĞLU, İbrahim Celalettin;
ÖZCEBE, Osman İlhami;
BÜYÜKAŞIK, Yahya

Publication type:

Article

Refractory immune thrombocytopenia – case presentation.

Published in:

Oncolog-Hematolog, 2022, n. 59, p. 29

By:

Iordan, Iuliana;
Neculcea, Andreea;
Mihai, Stejara;
Bonea, Diana;
Spînu, Andreea;
Mititelu, Alina;
Popescu, Claudiu;
Truican, Raluca;
Nicolescu, Anca;
Vlădăreanu, Ana Maria

Publication type:

Article

Eltrombopag with or without Tacrolimus for relapsed/refractory acquired aplastic anaemia: a prospective randomized trial.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00921-8

By:

Ji, Jiang;
Wan, Ziqi;
Ruan, Jing;
Yang, Yuan;
Hu, Qinglin;
Chen, Zesong;
Yang, Chen;
Chen, Miao;
Han, Bing

Publication type:

Article

The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.

Published in:

Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010031

By:

Vogel, Jens-Uwe;
Schmidt, Sophie;
Schmidt, Daniel;
Rothweiler, Florian;
Koch, Benjamin;
Baer, Patrick;
Rabenau, Holger;
Michel, Detlef;
Stamminger, Thomas;
Michaelis, Martin;
Cinatl, Jindrich

Publication type:

Article

Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis.

Published in:

Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582686

By:

Meng, Fanqiao;
Chen, Xiuqiong;
Yu, Shunjie;
Ren, Xiaotong;
Liu, Zhaoyun;
Fu, Rong;
Li, Lijuan

Publication type:

Article

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature.

Published in:

Transfusion Medicine, 2016, v. 26, n. 3, p. 202, doi. 10.1111/tme.12300

By:

Dyba, J.;
Tinmouth, A.;
Bredeson, C.;
Matthews, J.;
Allan, D. S.

Publication type:

Article

Catastrophic anti-phospholipid syndrome with Libman-Sacks endocarditis following eltrombopag therapy for immune thrombocytopenic purpura: A case report.

Published in:

2021

By:

Dichtwald, Sara;
Meyer, Avraham;
Ifrach, Nisim

Publication type:

Case Study

Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.

Published in:

Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1215, doi. 10.3390/ph16091215

By:

Hamed, Eman Mostafa;
Ibrahim, Ahmed R. N.;
Meabed, Mohamed Hussein;
Khalaf, Ahmed M.;
El Demerdash, Doaa Mohamed;
Elgendy, Marwa O.;
Saeed, Haitham;
Salem, Heba F.;
Rabea, Hoda

Publication type:

Article

Eltrombopag as an Allosteric Inhibitor of the METTL3-14 Complex Affecting the m 6 A Methylation of RNA in Acute Myeloid Leukemia Cells.

Published in:

Pharmaceuticals (14248247), 2022, v. 15, n. 4, p. N.PAG, doi. 10.3390/ph15040440

By:

Lee, Je-Heon;
Choi, Namjeong;
Kim, Subin;
Jin, Mi Sun;
Shen, Haihong;
Kim, Yong-Chul

Publication type:

Article

Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature.

Published in:

Pharmaceuticals (14248247), 2022, v. 15, n. 4, p. N.PAG, doi. 10.3390/ph15040419

By:

Bortolotti, Marta;
Pettine, Loredana;
Zaninoni, Anna;
Croci, Giorgio Alberto;
Barcellini, Wilma;
Fattizzo, Bruno

Publication type:

Article

Comprehensive characterization and resolution of discrepant spectrophotometric bilirubin results in patients on eltrombopag therapy.

Published in:

Clinical Chemistry & Laboratory Medicine, 2020, v. 58, n. 10, p. 1713, doi. 10.1515/cclm-2019-0684

By:

Cheng, Timothy H.T.;
Tsui, Teresa K.C.;
Kwok, Jeffrey S.S.;
Lit, Lydia C.W.;
Wong, Elaine Y.L.;
Kam, Richard K.T.;
Grote-Koska, Denis;
Staaden, Antje;
Okada, Hitoshi;
Fuke, Noriko;
Wong, Raymond S.M.;
Li, Chi-Kong;
Chan, Michael H.M.

Publication type:

Article

Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1507, doi. 10.1007/s00280-013-2150-9

By:

Hayes, Siobhan;
Mudd, Paul;
Ouellet, Daniele;
Johnson, Brendan;
Williams, Daphne;
Gibiansky, Ekaterina

Publication type:

Article

Effectiveness and safety of eltrombopag in connective tissue disease patients with refractory immune thrombocytopenia: a retrospective study.

Published in:

Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae029

By:

Jiang, Xiangpin;
Shu, Xiaoming;
Ge, Yongpeng

Publication type:

Article

Repurposing Eltrombopag for Multidrug Resistant Staphylococcus aureus Infections.

Published in:

Antibiotics (2079-6382), 2021, v. 10, n. 11, p. 1372, doi. 10.3390/antibiotics10111372

By:

Lee, Hyunjung;
Lee, Jaehoan;
Hwang, Juchan;
Park, Sinyoung;
Kim, Namyoul;
Kim, Kideok;
Lee, Honggun;
Shum, David;
Jang, Soojin

Publication type:

Article

Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus.

Published in:

Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2021.790686

By:

She, Pengfei;
Li, Shijia;
Zhou, Linying;
Liu, Yaqian;
Xu, Lanlan;
Hussain, Zubair;
Li, Yimin;
Li, Zehao;
Liu, Shasha;
Wu, Yong

Publication type:

Article

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.

Published in:

Hepatic Medicine: Evidence & Research, 2013, v. 5, p. 17, doi. 10.2147/HMER.S27100

By:

Danish, Fazal-i-Akbar;
Yasmin, Saeeda

Publication type:

Article

艾曲泊帕治疗儿童免疫性血小板减少症的Meta 分析.

Published in:

Chinese Journal of Contemporary Pediatrics, 2021, v. 23, n. 9, p. 944, doi. 10.7499/j.issn.1008-8830.2103070

By:

许金云;
王勇;
吴勇;
顾教伟

Publication type:

Article

Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP).

Published in:

British Journal of Haematology, 2013, v. 160, n. 4, p. 538, doi. 10.1111/bjh.12169

By:

Bussel, James B.;
Saleh, Mansoor N.;
Vasey, Sandra Y.;
Mayer, Bhabita;
Arning, Michael;
Stone, Nicole L.

Publication type:

Article

Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3164, doi. 10.3390/ijms24043164

By:

Chen, Yao;
Zhang, Rui;
Yang, Liuqing;
Zhang, Pei;
Wang, Feiyun;
Lin, Guoqiang;
Zhang, Jiange;
Zhu, Yuying

Publication type:

Article

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 6907, doi. 10.3390/ijms22136907

By:

Lozano, Maria L.;
Segú-Vergés, Cristina;
Coma, Mireia;
Álvarez-Roman, María T.;
González-Porras, José R.;
Gutiérrez, Laura;
Valcárcel, David;
Butta, Nora

Publication type:

Article

Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 97, doi. 10.3390/ijms22010097

By:

Di Paola, Alessandra;
Palumbo, Giuseppe;
Merli, Pietro;
Argenziano, Maura;
Tortora, Chiara;
Strocchio, Luisa;
Roberti, Domenico;
Santoro, Claudia;
Perrotta, Silverio;
Rossi, Francesca

Publication type:

Article

Predictive factors of response to eltrombopag and romiplostim in Egyptian immune thrombocytopenia patients: a single center experience.

Published in:

Egyptian Journal of Haematology, 2023, v. 48, n. 1, p. 88, doi. 10.4103/ejh.ejh_30_23

By:

El Demerdash, Doaa;
Mohamady, Nagham;
Abdelghany, Wafaa;
Youssef, Heba

Publication type:

Article

Therapeutic roles of hematopoietic growth factors: treatment with a thrombopoietin mimetic (Eltrombopag) and cyclosporin A in aplastic anemia.

Published in:

Egyptian Journal of Haematology, 2022, v. 47, n. 2, p. 105, doi. 10.4103/ejh.ejh_11_22

By:

Khaled, Safaa;
Mahmoud, Maged;
Mahran, Dalia;
Abdelaal, Sawsan;
Hussein, Safinaz

Publication type:

Article

Eltrombopag as first‐line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 2023, doi. 10.1111/bcp.14607

By:

Qiu, Kun‐yin;
Liao, Xiong‐yu;
Huang, Ke;
Wu, Ruo‐hao;
Xu, Hong‐gui;
Xu, Lu‐hong;
Li, Yang;
Weng, Wen‐jun;
Zhou, Dun‐hua;
Fang, Jian‐pei

Publication type:

Article

Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.

Published in:

Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.019

By:

Napolitano, Mariasanta;
Vianelli, Nicola;
Ghiotto, Lisanna;
Cantoni, Silvia;
Carli, Giuseppe;
Carpenedo, Monica;
Carrai, Valentina;
Consoli, Ugo;
Giuffrida, Gaetano;
Lucchini, Elisa;
Rossi, Elena;
Santoro, Cristina;
Rodeghiero, Francesco

Publication type:

Article

Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag.

Published in:

Science Translational Medicine, 2018, v. 10, n. 458, p. 1, doi. 10.1126/scitranslmed.aas9563

By:

Kao, Yun-Ruei;
Chen, Jiahao;
Narayanagari, Swathi-Rao;
Todorova, Tihomira I.;
Aivalioti, Maria M.;
Ferreira, Mariana;
Ramos, Pedro M.;
Pallaud, Celine;
Mantzaris, Ioannis;
Shastri, Aditi;
Bussel, James B.;
Verma, Amit;
Steidl, Ulrich;
Will, Britta

Publication type:

Article

DOSE RATIONALE BIOEQUIVALENCE ASSESSMENT UNDER FASTING CONDITIONS OF ELTROMBOPAG FOR BIOWAIVER MANUFACTURED IN TÜRKİYE.

Published in:

Nobel Medicus Journal, 2025, v. 21, n. 1, p. 22

By:

Uslu, Abdullah;
Güçarslan, İlksen;
Sağıroğlu, Bclkıs;
Sağlam, Onursal;
Nacak, Muradiye;
Pilancı, Aybige;
Kökçe, Sena Damla;
Yeşilyurt, Tuğçe

Publication type:

Article

Stable Liver Function during Long-Term Administration of Eltrombopag, a Thrombopoietin Receptor Agonist, in Patients with Chronic Liver Disease.

Published in:

Tohoku Journal of Experimental Medicine, 2016, v. 240, n. 4, p. 277, doi. 10.1620/tjem.240.277

By:

Tomohiro Kurokawa;
Soichiro Murata;
Nobuhiro Ohkohchi

Publication type:

Article

Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non‐inferiority, randomized controlled trial.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 777, doi. 10.1002/hon.3017

By:

Wen, Bingbing;
Zhang, Xiaohan;
Chen, Shiyu;
Fan, Jingchao;
Yang, Sitian;
Cai, Yun;
Wang, Pengcheng;
Zhang, Qiaoxia;
Gu, Qingli;
Du, Xin

Publication type:

Article

Identification of Eltrombopag as a Repurposing Drug Against Staphylococcus epidermidis and its Biofilms.

Published in:

Current Microbiology, 2021, v. 78, n. 4, p. 1159, doi. 10.1007/s00284-021-02386-z

By:

Zhu, Juan;
She, Pengfei;
Fu, Juhua;
Peng, Canhui;
Wu, Yong

Publication type:

Article